Fetal cardiomyocytes have been proposed as a potential source of cell-based therapy for heart failure. This study examined cellular senescence in cultured human fetal ventricular cardiomyocytes (HFCs). HFCs were isolated and identified by immunocytochemistry and RT-PCR. Cells were found to senesce after 20-25 population doublings, as determined by growth arrest, morphological changes and senescence-associated β β β β -galactosidase activity. Using the telomeric repeat amplification protocol assay, telomerase activity was undetectable in primary HFCs. Cells were transduced to express the human reverse transcriptase subunit (hTERT) of telomerase. This resulted in greatly increased telomerase activity, but no significant lifespan extension. Analysis of telomere length in primary HFCs revealed that the senescent phenotype was not accompanied by telomere shortening. Telomeres in hTERT-positive cells were elongated in comparison with primary cells, and elongation was retained in senescent cells. Levels of the tumor suppressor protein p16 INK4A increased in all senescent cells whether telomerase-positive or -negative. Senescence was accompanied by a decline in transcript levels of the polycomb gene Bmi-1, Ets1 and Ets2 transcription factors, and Id1, Id2 and Id3 helix-loop-helix proteins, suggesting roles for these genes in maintenance of cardiomyocyte proliferative capacity. In addition to offering novel insights into the behavior of human fetal cardiomyocytes in culture, these findings have implications for the development of a cell-based therapy for cardiac injury using primary fetal heart tissue.
Introduction
The regenerative capacity of the adult human heart is extremely limited. Consequently, when heart muscle is damaged and cardiomyocytes are lost, contractile tissue is not significantly regenerated, and scar formation occurs. Cardiac transplantation remains the treatment of choice for end-stage heart failure, but is limited by a shortage of donor organs, complications of immunosuppression and graft vasculopathy (Hunt, 1998) . A cell-based therapy for heart failure is extremely attractive as an alternative to cardiac transplantation but has been limited by the lack of a supply of appropriate cells. Unfortunately, adult mammalian cardiomyocytes are predominantly post-mitotic and so cannot be expanded in vitro . Therefore, alternative cell sources have been investigated in recent years, with varying and occasionally disputed results. Candidates include fetal cardiomyocytes (Soonpaa et al ., 1994; Reffelmann et al ., 2003) , skeletal myoblasts (Taylor et al ., 1998; Reinecke et al ., 2004) and embryonic stem cells (Dowell et al ., 2003; Kehat & Gepstein, 2003) . Hematopoietic stem cells have been reported to regenerate infarcted myocardium (Orlic et al ., 2001) , although these findings have been called into question (Balsam et al ., 2004; Murry et al ., 2004) . Recently, progenitor cells in adult heart that show stem cell characteristics have been described (Beltrami et al ., 2003; Oh et al ., 2003) , and these may provide novel opportunities for myocardial repair.
Unlike the adult, fetal cardiomyocytes in vitro have been shown to proliferate (Goldman & Wurzel, 1992; Burton et al ., 1999) . Moreover, transplant studies have shown that fetal cardiomyocytes can survive and become stably integrated into normal and injured adult hearts, leading to beneficial effects upon cardiac function. They are capable of forming intercalated disks with host cardiomyocytes, developing sarcomeric structures and other morphological features of differentiation and becoming functionally coupled (Reffelmann et al ., 2003; Dowell et al ., 2003; Rubart et al ., 2003) . These findings suggest that fetal cardiomyocytes may represent the optimal cell type for therapy of heart failure (Chien, 2004) .
A major difficulty with utilizing fetal cardiomyocytes is the limited availability of human fetal tissue (Reffelmann et al ., 2003) . Thus, the fact that fetal cardiomyocytes can replicate in vitro will be critical to generating a sufficient number of cells for transplantation. Although earlier studies have shown that fetal human cardiomyocytes are capable of proliferating in tissue culture in the presence of serum, those studies did not examine the proliferative capacity in detail (Goldman & Wurzel, 1992; Burton et al ., 1999) . Here, we examine more extensively the proliferative ability and behavior of isolated human fetal cardiomyocytes in culture. We found that cells isolated from 22-to 24-week-gestation human hearts and positively identified as cardiomyocytes have a proliferative capacity of approximately 20 population doublings (PDs) under normal culture conditions. The growth arrest that occurred after 20 PDs had some characteristics of cellular senescence but is not due to telomere shortening as shown by telomere length determination and lack of responsiveness to human reverse transcriptase subunit (hTERT)induced telomere lengthening.
Results

Identification of isolated cells as cardiomyocytes
The cardiomyocyte isolation procedure of collagenase digestion and gradient centrifugation yielded a population of cells that exhibited a remarkable degree of morphological homogeneity. No spindle-shaped fibroblastic cells could be seen. Immunocytochemical analysis revealed that all cells in the isolated cultures were positive for sarcomeric myosin heavy chain ( Fig. 1A) and for α -sarcomeric actinin, a prototypical Z-line protein (Fig. 1B) . These results indicate that the initial cultures consisted essentially of pure cardiomyocytes. Negative controls minus primary antibody confirmed that these observations were not due to cellular autofluorescence (data not shown).
To characterize further the cells isolated from the fetal heart, RT-PCR analysis was employed. Figure 1 (C) shows mRNA transcript expression of a wide range of markers of cardiomyocyte lineage and function. The isolated fetal heart cells (middle lane) express transcription factors known to regulate cardiomyocyte development -GATA4, Nkx2.5 and TBX5. Other important cardiac genes present were ventricular myosin light chain (MLC-2v), titin and cardiac troponin T (cTNT). Additionally, human fetal ventricular cardiomyocytes (HFCs) did not express CD31 or von Willebrand Factor (vWF), indicating that cultures were not contaminated with endothelial cells. Human diploid fibroblasts were used as negative controls (right lane), and GAPDH served as an internal loading control. Positive controls (left lane) were fetal human heart (GATA4, Nkx2.5, TBX5, MLC-2v, Titin, cTNT, GAPDH) and lung (CD31 and vWF).
Using this semi-quantitative method, transcript levels of all cardiomyocyte markers studied in early passage proliferating isolated heart cells appear to be similar to those in fetal human heart.
Senescence of primary fetal cardiomyocytes in culture
Isolated fetal cardiomyocytes were cultured in Dulbecco's modified Eagle medium with high glucose and 10% fetal bovine serum and were found to proliferate under these conditions. The lifespan of the cells was determined by continuous passage. Cells were found to show steadily increasing doubling times and finally underwent growth arrest after 20-25 PDs (Fig. 2) . Growth arrest of primary cells was accompanied by up-regulation of senescence-associated (SA) β -galactosidase activity ( Fig. 3C ) and increased expression of the p16 INK4A tumor suppressor protein (see Fig. 5 , lane 4). SA β -galactosidase and p16 INK4A are widely recognized as indicators of cellular senescence (Dimri et al ., 1995; Sharpless & DePinho, 2004) .
Telomerase activity in hTERT-infected and uninfected cells
Telomerase is a multisubunit riboprotein that maintains telomere length in germ cells, stem cells and many immortal cell lines. Telomerase activity is absent in most normal somatic cells due to the lack of expression of the telomerase reverse transcriptase subunit, but can be induced by exogenous expression of that gene, which functions in a species-specific manner. The human homologue, hTERT, has been shown to immortalize primary human fibroblasts (Bodnar et al ., 1998) , which otherwise have a finite lifespan in culture due to cellular senescence. Like fibroblasts, cardiomyocytes are of mesenchymal lineage, and thus we examined whether hTERT could similarly extend the lifespan of primary HFCs in culture. A Moloney murine-derived retroviral vector, LTRTNLlox, was used to introduce hTERT into isolated HFCs. This vector has previously been demonstrated to be capable of extending the proliferative lifespan of primary human fibroblasts and immortalizing human pancreatic cell lines (Halvorsen et al ., 1999) . Proliferating HFC cells were infected with hTERT expressing retrovirus after approximately 1 PD. hTERT-positive cells were then selected using hygromycin as a selectable marker. Figure 4 shows the relative telomerase activity in the primary HFC cells and hTERT-positive HFC cells. Infection with hTERT significantly ( P < 0.001) increased telomerase activity in the proliferating cells (0-4 PDs), and its activity was unchanged in both telomerase-positive and -negative cells that had undergone growth arrest (20-25 PDs).
Accumulation of senescence-associated β β β
βgalactosidase is independent of telomerase activity HFC cells, with or without telomerase, were cultured continuously and their proliferative ability determined. In every case, cultured cells entered a period of enlarged morphology and slowed growth. After 20 -25 PDs, all cultures were completely growtharrested ( Fig. 2 ). Loss of proliferation was invariably accompanied by morphological changes, including enlargement and vacuolization of the cell body ( Fig. 3C,D) . We consistently observed no significant extension of the proliferative lifespan in hTERT-transduced cells. Up-regulation of SA β -galactosidase activity has been recognized as a marker of cellular senescence (Dimri et al ., 1995) . SA β -galactosidase expression was detected in growth-arrested primary HFC cells and hygromicin-selected hTERT-positive cells ( Fig. 3C,D) . The growth arrest was not due to failure of the vector to express hTERT because telomerase activity was present in hTERT-transgenic cells even after the cells stopped dividing, as demonstrated by telomeric repeat amplification protocol ( TRAP) (Fig. 4) . In proliferating cardiomyocytes, with or without telomerase, activity of SA β -galactosidase was negligible (Fig. 3A,B ).
p16 INK4A levels in cells undergoing growth arrest
Expression of the p16 INK4A tumor suppressor protein increases in senescent cells (Sharpless & DePinho, 2004) , and may play a role in senescence-related growth arrest. Therefore, we compared p16 INK4A levels in early-passage and growth-arrested cells by Western blot. Extracts prepared from proliferating cardiomyocytes with or without telomerase that had undergone 0 -4 PDs contained low levels of p16 INK4A protein (Fig. 5 , lanes 3 and 5).
In sharp contrast, p16 INK4A was more highly expressed in growtharrested primary cardiomyocytes. Similar to β -galactosidase expression, hTERT had no effect on the increase in p16 INK4A that occurred with increasing passage (Fig. 5, lanes 4 and 6) .
HFC growth-arrest is independent of telomere shortening
Cellular senescence commonly occurs as a result of telomere shortening during DNA replication. In primary human diploid fibroblasts, the best-studied model of senescence, telomere erosion occurs over more than 40 cell divisions before growth arrest due to senescence (Harley et al ., 1990) . As the cardiomyocyte cultures undergo growth arrest after only 20 -22 PDs, we were particularly interested in examining telomere length dynamics in these cells. Samples of genomic DNA from early-(actively dividing) and late-(growth-arrested) passage primary cardiomy-ocytes and telomerase-infected cardiomyocytes were isolated for telomere length analysis by Southern blot (Fig. 6 ). The telomere lengths of maximally expanded primary HFCs (Lane 4) were not found to be substantially shorter than those of proliferating early-passage cells (Lane 3). Interestingly, telomeres of hTERT-positive cells (Lanes 5 and 6) were elongated in comparison with cells that had not been infected with virus-expressing telomerase (Lanes 3 and 4), and no difference in average telomere length between proliferating and growth-arrested telomerase-infected samples was observed (Lanes 5 and 6). Thus, increasing the telomere length had no effect on the kinetics of growth of HFCs.
HFC growth-arrest is not prevented by culture in low oxygen conditions
Under normal conditions, cell culture is performed at ambient oxygen levels (20%), considerably higher than the levels thought to exist in the human heart (Winegrad et al ., 1999) . Studies have shown that in certain cell types ambient oxygen induces oxidative stress and limits cell growth (Busuttil et al ., 2003; Parrinello et al ., 2003; Martin et al ., 2004) . To examine whether oxidative stress was underlying the growth arrest observed in primary HFC, we cultured these cells in the continuous presence of an oxygen concentration of 1% -a level that is within the physiologic range for cardiomyocytes (Roy et al ., 2003) . To reduce the level of oxidative stress further, tissue culture medium was supplemented with 1 m M N -acetyl cysteine, a free radical scavenger that extends lifespan in some cells (Haendeler et al ., 2004) . N -acetyl cysteine and 1% oxygen were unable to prolong the lifespan of primary HFC. As with cells cultured in the presence of ambient oxygen (normoxia), cells cultured in the presence of 1% oxygen (hypoxia) growtharrested after 20 -24 PDs (Fig. 7A ). Growth-arrested cells showed the enlarged, flattened morphology characteristic of senescent cells (Fig. 7B) , and Southern blot analysis revealed that culture of cells in the presence of hypoxic conditions and a free radical scavenger had no beneficial protective effect on telomere length in these cells (Fig. 7C ).
Transcript levels of Bmi-1 decrease in senescent cardiomyocytes
The Polycomb gene Bmi-1 is a transcriptional repressor of the INK4A locus (Jacobs et al ., 1999) , which in humans encodes the tumor suppressor proteins p16 and p14 ARF . In human lung (WI-38) fibroblasts, overexpression of Bmi-1 increases replicative lifespan by suppressing the p16 INK4A senescence pathway (Itahana et al ., 2003) . Conversely, senescence in human WI-38 fibroblasts is accompanied by a decline in endogenous Bmi-1 levels, suggesting that Bmi-1 contributes to the senescence program in these cells (Itahana et al ., 2003) . Using a quantitative real-time RT-PCR approach, we measured the expression of Bmi-1 transcripts in proliferating and senescent HFCs in the absence or presence of exogenous telomerase (Fig. 8A) . In senescent primary HFCs, Bmi-1 levels were significantly decreased ( P < 0.001) compared with presenescent cells. Similarly, in HFCs transduced with hTERT, senescent cells showed a significant ( P < 0.001) decline in Bmi-1 levels when compared with earlier passage presenescent cells (Fig. 8A ). (Lyden et al ., 1999) , and loss of Id function has been linked to replicative senescence in human fibroblasts (Hara et al ., 1994) . To determine whether changes in Ets and/or Ids expression might accompany p16 INK4A expression in senescent HFCs, we utilized quantitative real-time RT-PCR to examine relative expression of Ets1, Ets2, Id1, Id2 and Id3 mRNA transcript levels in proliferating and growth-arrested HFCs in the absence or presence of the hTERT gene ( Fig. 8B-F) . Each of these genes showed a significant reduction ( P < 0.001) in transcript expression in growth-arrested cells (20 -22 PDs). With each gene studied, this reduction was observed in both primary HFC cells and HFC cells that had been infected with telomerase.
Reduced transcription of Ets and Id in growth-arrested cardiomyocytes
Discussion
Our results indicate that HFCs have a limited proliferative capacity and that cellular senescence is responsible for the proliferative failure that occurs after 20-25 PDs. We have demonstrated that the cellular senescence program underlying growth arrest in cultured human fetal cardiomyocytes is independent of telomerase activity and telomere length, but is accompanied by increased p16 INK4A and β -galactosidase expression along with a reduction in the expression of Bmi-1, Ets and Id genes. Cellular senescence occurs in human somatic cells grown in culture following a limited number of PDs, and is accompanied by growth arrest, morphological changes and increased expression of the p16 INK4A tumor suppressor protein (Duncan et al., 2000) and senescence-associated markers such as SA βgalactosidase. The most commonly described model of senescence proposes that the process is due to telomere shortening. Expression of exogenous TERT has been shown to restore telomere lengths and extend cellular lifespan (Bodnar et al., 1998; Halvorsen et al., 1999; Duncan et al., 2000) . In some cases, such as primary human fibroblasts, TERT is sufficient to immortalize cells without causing transformation or compromising genomic stability (Jiang et al., 1999; Vaziri et al., 1999) . Although telomere length plays a major role in senescence in many cell types, additional factors are clearly involved. For instance, senescence in human keratinocytes is associated with loss of telomerase activity without shortening of telomeres (Kang et al., 1998) . In astrocytes, a proliferative lifespan barrier exists that is independent of telomere length but is associated with increased SA β-galactosidase and p16 INK4A (Evans et al., 2003) . In human pancreatic beta-cells, growth arrest is accompanied by extremely rapid shortening of telomeres and increased expression of SA β-galactosidase and p16 INK4A . However, the senescent phenotype was not prevented by retroviral induction of the hTERT gene, despite telomerase activity being induced (Halvorsen et al., 2000) . Taken together, these data indicate that telomerelength-independent mechanisms can induce senescence in human somatic cells, and that different cell types may utilize different senescence pathways.
To determine whether the limited proliferative ability of primary fetal cardiomyocytes was caused by a lack of telomerase activity, we examined the effects of exogenous telomerase upon lifespan of these cells using a retroviral hTERT vector which has been previously demonstrated to extend the proliferative lifespan of primary human fibroblasts and immortalize human pancreatic cell lines (Halvorsen et al., 1999) . We found that transduction of the hTERT gene and induction of telomerase activity had no observable effect on the proliferative lifespan of human fetal cardiomyocytes, despite a clear telomeric elongation mediated by hTERT. This suggests that additional signals other than telomere shortening may activate or enforce the HFC senescence program and that the replicative fate of cultured HFCs is not determined simply by a mitotic clock of telomere length.
In common with many telomere-dependent and -independent models of senescence, we observed a marked up-regulation of p16 INK4A expression in growth-arrested fetal cardiomyocytes. This up-regulation was observed in all senescent cultures studied, whether with or without induced telomerase activity. These findings are in keeping with recent reports showing increased levels of p16 INK4A in cardiomyocytes from aging mice (Torella et al., 2004) and
in aging diseased human hearts . However, the in vivo studies found that cardiomyocyte senescence is accompanied by telomere shortening, in contrast to our in vitro data. Of all the characteristics of senescent cells, up-regulation of p16 INK4A seems to be the most universal. We have shown that HFCs can have their lifespan significantly extended by forced expression of a mutant CDK4 that inhibits the binding of p16 INK4A (Ball et al., 2004) . These cells eventually senesce accompanied by telomere shortening, suggesting that the senescence program reported here in primary HFC cells is p16 INK4A -mediated. Thus, understanding the inputs into p16 INK4A gene expression may provide important insights into the regulation of HFC senescence. The INK4A locus is known to be repressed by the Polycomb protein Bmi-1 (Jacobs et al., 1999) . A recent study in human WI-38 fibroblasts reported that overexpression of Bmi-1 rescues these cells from extrinsic (telomereindependent) senescence and extends their replicative lifespan by repressing p16 (Itahana et al., 2003) . We used quantitative RT-PCR to examine Bmi-1 transcripts in proliferating and senescent HFCs with or without telomerase and found that senescence was accompanied by a marked decline in Bmi-1 levels, concomitant with the increased expression of p16 INK4A . Thus it appears that the telomere-independent senescence observed in cultured HFCs may in part be mediated by a decline in Bmi-1 levels and that the consequent decline in repression of the INK4A locus leads to the increased expression of p16 observed in senescent HFCs. In addition to Bmi-1, Ets-domain and Id helix-loop-helix transcription factor proteins (Benezra et al., 1990; Sharrocks, 2001) are thought to play a role in regulating p16 INK4A expression, and ectopic expression of Id1, 2 and 3 has been shown to increase the lifespan of human keratinocytes (Alani et al., 1999; Nickoloff et al., 2000) . We examined Ets1, Ets2, Id1, Id2 and Id3 expression in senescent cardiomyocytes. Levels of each were found to be significantly reduced in senescent cells, and expression of exogenous telomerase had no effect on Id or Ets expression. These data suggest a possible role for Ets and Ids in mediating p16 INK4A expression in aging cardiomyocytes. The reduction in Id expression is consistent with the roles defined for these in other cell types. However, the reduction in both Ets1 and Ets2 differs from observations in senescent human fibroblasts, where Ets factors increase in senescent cells (Ohtani et al., 2001) . It is important to note that the Ets family of transcription factors comprises many members (Sharrocks, 2001) , and it is conceivable that different members may increase in expression to regulate p16 INK4A in different cell types. Our findings provide the first evidence of a correlation between Bmi-1, Ets, Id and increased p16 INK4A expression in cardiomyocytes, and may provide a basis for studies examining the nature of the increased p16 INK4A expression observed in aging and diseased human heart. In addition to shedding new light on the behavior of fetal cardiomyocytes in culture, this study has implications for the development of a cell-based therapy for cardiac injury using primary fetal heart tissue. If transplantation of fetal cardiomyocytes is to become clinically effective in the treatment of heart failure, an approach to bypassing cellular senescence must be found.
Experimental procedures Isolation and culture of human fetal heart cells
Ventricular cardiomyocytes from human fetal hearts of 22-24 weeks gestation (Advanced Bioscience Resources) were isolated by collagenase digestion of ventricular tissue followed by Percoll gradient centrifugation (Goldman & Wurzel, 1992) . Cell cultures were maintained in a humidified environment in the presence of 10% CO 2 and atmospheric (20%) O 2 . Cultures were fed with Dulbecco's modified Eagle medium with high glucose and 10% fetal bovine serum every 3 days, and subcultured by trypsinization when cells neared confluence. At each passage, cell number was determined and PD values calculated. In studies examining the role of reduced O 2 levels upon proliferative lifespan, cells were cultured continuously in a Ruskinn INVIVO 2 400 anaerobic workstation maintaining 1% O 2 .
Infection with hTERT retroviral vector
Isolated ventricular cardiomyocytes were infected after 1 PD with an hTERT-expressing retroviral vector (Halvorsen et al., 1999) and selected in 100 µg mL −1 hygromycin. A resistant hTERT-positive population was obtained and expanded in the same manner as primary ventricular cardiomyocytes.
Immunocytochemistry
Immunostaining was performed on cell monolayers fixed in 4% paraformaldehyde. Primary antibodies were monoclonal anti- Senescence-associated galactosidase activity was localized as described previously (Halvorsen et al., 2000) .
RT-PCR for cardiomyocyte markers
RT-PCR was performed as described previously (Dufayet 
TRAP assay
Quantitative determination of telomerase activity was performed using the TRAP procedure with the TeloTAGGG telomerase PCR ELISA kit (Roche) according to the manufacturer's instructions. Integrity of assay was determined by using heat-inactivated samples as negative controls and telomerase-expressing 293 cell samples as positive controls.
Telomere length assay
Telomere length was determined by Southern blot analysis of terminal restriction fragments obtained by the digestion of genomic DNA, using a TeloTAGGG Telomere Length Assay kit (Roche). Briefly, genomic DNA was isolated then digested with RsaI/HinfI, separated on a 0.8% agarose gel, transferred to a positively charged nylon membrane (Roche) and hybridized with a telomere-specific, DIG-labeled probe, which was incubated with anti-DIG-alkaline phosphatase and detected by chemiluminescence.
Western blot for p16
INK4A
Cells from monolayer cultures were lysed using RIPA buffer (Boston Bioproducts) containing a protease inhibitor cocktail (Calbiochem). Expression of p16 INK4A was determined by Western blot analysis of 10 µg protein with an anti-human p16 INK4A monoclonal antibody (Pharmingen, San Diego, CA, USA). The same membrane was reprobed with anti-actin rabbit antibody A2066 (Sigma) to verify that equivalent amounts of protein were loaded onto each lane. Bound antibody was detected with horseradish peroxidase-linked anti-mouse or anti-rabbit Ig (Amersham Pharmacia Biotech, Little Chalfont, UK) and enhanced chemiluminescence (Amersham Pharmacia Biotech).
Statistical analysis
Results are presented as mean ± standard error of the mean (SEM) for a given number of observations (n). Groups of data were compared using unpaired Student's t-test. 
